APPLICATION OF A TWO-STEP SCREENING SYSTEM IN COMPLEX EVALUATION OF PSYCHOSOCIAL STATUS IN PATIENTS WITH CORONARY HEART DISEASE
Objective: To study the features of the clinical and psychosocial profile using a two-step screening system in patients with coronary heart disease (CHD). Methods: In 115 patients with the stable CHD, conducted a general clinical examination with an assessment of the psychosocial status using the...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Avicenna Tajik State Medical University
2017-06-01
|
| Series: | Паёми Сино |
| Subjects: | |
| Online Access: | https://doi.org/10.25005/2074-0581-2017-19-2-167-171 |
| Summary: | Objective: To study the features of the clinical and psychosocial profile using a two-step screening system in patients with coronary heart disease (CHD).
Methods: In 115 patients with the stable CHD, conducted a general clinical examination with an assessment of the psychosocial status using the European Society of Cardiologists Questionnaire, the scales of the anxiety and depression of Hamilton, and the DS-14 questionnaire.
Results: Analysis of the clinical status revealed a severe course of CHD in more than 40% of patients prevailing conditional risk factors (arterial hypertension, obesity, dyslipidemia), as well as low adherence to medicamentous therapy (statins, nitrates, calcium blockers, diuretics) and interventional procedures. The psychological status of those surveyed was characterized by a high rate of hostility (36.5%), personality type D (29.5%), anxiety (16.5%) and depression (6.9%), low socioeconomic status (6.9%), stress at work and in family life (6%).
Conclusion: The two-step screening system with application of European Society of Cardiologists Questionnaire, Hamilton’s anxiety and depression scales, DS-14 questionnaire are recommended to use for well-timed verification of psychosocial risk factors in coronary heart disease patients with the aim to detect existing barriers to treatment and to optimize treatment and medioprophylactic measures. |
|---|---|
| ISSN: | 2074-0581 2959-6327 |